Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Learn more about best practices for personal protective equipment during administration, compounding, and spill management of checkpoint inhibitors.
Learn how oncolytic viruses work along with the proper preparation, administration, post-administration, as well as helpful tips for the safe handling of oncolytic viruses through this engaging infographic.
Dr. Friend reviews biomarker basics, which sets an important foundation to understand how biomarkers and biomarker testing informs treatment decisions and oncology nursing care. She reviews the different types of biomarkers and the classification of variants so that you can use the right terms in practice when speaking to the patient or the healthcare team. She then applies what she taught through a multitude of case examples.
Watch this ONS video on the risk of handling hazardous drugs while pregnant.
In this case study, learn more about racial disparities that may exist around genetic testing for non-small cell lung cancer (NSCLC). Following this patient scenario, learners will be able to describe common causes of health disparities seen in NSCLC and review common biomarkers tested during the diagnosis of NSCLC.
Learn more about the FDA Medwatch program and how nurses can recognize and report adverse events through the Recognize it; Report it online resource.
The following ONS interim recommendations are for the use of PPE during clinical oncology care and for safe handling and administration of hazardous cancer drugs based on the Table 1 NIOSH list. The options are presented in descending order from highest-level recommended practice based on supplies of available PPE. Although ONS recognizes that these are not ideal, they are interim guidelines to support decision making and staff and patient safety in clinical care during the COVID-19 pandemic.
As COVID-19 coronavirus infections spread throughout the United States, appropriate and safe staffing is needed to meet patient needs across institutions. Hospitals and cancer centers are facing unique challenges in staffing and redeploying staff to other units. Many factors contribute to decisions about temporary reassignment of oncology staff outside of the oncology unit or ambulatory department.
Beltsville, MD